Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Italy.
Mol Cell Proteomics. 2011 Apr;10(4):M110.002964. doi: 10.1074/mcp.M110.002964. Epub 2010 Dec 14.
Mitochondrial diseases (MD) are heterogeneous disorders because of impairment of respiratory chain function leading to oxidative stress. We hypothesized that in MD the vascular endothelium may be affected by increased oxidative/nitrative stress causing a reduction of nitric oxide availability. We therefore, investigated the pathobiology of vasculature in MD patients by assaying the presence of 3-nitrotyrosine in muscle biopsies followed by the proteomic identification of proteins which undergo tyrosine nitration. We then measured the flow-mediated vasodilatation as a proof of altered nitric oxide generation/bioactivity. Here, we show that 3-nitrotyrosine staining is specifically located in the small vessels of muscle tissue and that the reaction is stronger and more evident in a significant percentage of vessels from MD patients as compared with controls. Eleven specific proteins which are nitrated under pathological conditions were identified; most of them are involved in energy metabolism and are located mainly in mitochondria. In MD patients the flow-mediated vasodilatation was reduced whereas baseline arterial diameters, blood flow velocity and endothelium-independent vasodilatation were similar to controls. The present results provide evidence that in MD the vessel wall is a target of increased oxidative/nitrative stress.
线粒体疾病(MD)是一种异质性疾病,因为呼吸链功能的损伤会导致氧化应激。我们假设在 MD 中,血管内皮可能会受到增加的氧化/硝化应激的影响,导致一氧化氮的可用性降低。因此,我们通过检测肌肉活检中 3-硝基酪氨酸的存在,以及对经历酪氨酸硝化的蛋白质进行蛋白质组学鉴定,来研究 MD 患者的血管病理学。然后,我们测量了血流介导的血管舒张,以证明一氧化氮生成/生物活性的改变。在这里,我们表明 3-硝基酪氨酸染色特异性地位于肌肉组织的小血管中,并且在与对照组相比,来自 MD 患者的血管中,该反应更强且更明显。在病理条件下,鉴定出了 11 种特异性硝化的蛋白质;其中大多数参与能量代谢,主要位于线粒体中。在 MD 患者中,血流介导的血管舒张减少,而基础动脉直径、血流速度和非内皮依赖性血管舒张与对照组相似。本研究结果提供了证据表明,在 MD 中,血管壁是增加的氧化/硝化应激的靶标。